Raymond James & Associates Global Blood Therapeutics, Inc. Transaction History

Raymond James & Associates

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$22.3 - $37.39 $142,117 - $238,286	-6,373 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$25.68 - $35.59 $14,432 - $20,001	-562 Reduced 8.1%	6,373 $221,000
Q4 2021 Feb 08, 2022	SELL	$24.9 - $40.26 $180,151 - $291,281	-7,235 Reduced 51.06%	6,935 $203,000
Q3 2021 Nov 02, 2021	BUY	$25.48 - $37.34 $156,702 - $229,641	6,150 Added 76.68%	14,170 $361,000
Q2 2021 Aug 11, 2021	SELL	$32.46 - $43.42 $57,843 - $77,374	-1,782 Reduced 18.18%	8,020 $281,000
Q1 2021 May 14, 2021	SELL	$38.94 - $50.85 $55,294 - $72,207	-1,420 Reduced 12.65%	9,802 $399,000
Q4 2020 Feb 12, 2021	SELL	$37.65 - $63.77 $57,905 - $98,078	-1,538 Reduced 12.05%	11,222 $486,000
Q3 2020 Nov 04, 2020	SELL	$52.76 - $74.49 $363,305 - $512,938	-6,886 Reduced 35.05%	12,760 $704,000
Q2 2020 Jul 28, 2020	BUY	$48.73 - $81.82 $132,935 - $223,204	2,728 Added 16.12%	19,646 $1.24 Million
Q1 2020 Apr 21, 2020	SELL	$41.72 - $87.2 $202,133 - $422,484	-4,845 Reduced 22.26%	16,918 $864,000
Q4 2019 Feb 12, 2020	BUY	$45.7 - $81.86 $198,246 - $355,108	4,338 Added 24.9%	21,763 $1.73 Million
Q3 2019 Nov 07, 2019	BUY	$45.35 - $57.91 $372,368 - $475,499	8,211 Added 89.11%	17,425 $845,000
Q2 2019 Aug 06, 2019	BUY	$52.6 - $63.29 $484,656 - $583,154	9,214 New	9,214 $485,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.